Why the study?
Does mesenchymal stem cell administration improve cardiac function and repair in mice following acute myocardial infarction, and is this dependent on myocardial CXCR4 expression?
Population
Conditional cardiac myocyte CXCR4 null mice and wild-type littermates subjected to acute myocardial infarction
Comparison
100,000 mesenchymal stem cells administered via… vs Saline administered via tail vein
Design
Preclinical
Follow-up
4, 7, and 21 days
Authors
Loading...
MSC benefit in murine post-MI repair requires myocyte CXCR4; leaves open translation to human cell therapy trials.
Does mesenchymal stem cell administration improve cardiac function and repair in mice following acute myocardial infarction, and is this dependent on myocardial CXCR4 expression?
Mesenchymal stem cell-mediated cardiac repair following acute myocardial infarction requires cardiac myocyte CXCR4 expression to achieve functional benefits.
Dong et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: